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Summary.-Patients with melanoma who had one or more close relatives with
melanoma were studied for their natural-killer-cell (NK) activity against cultured
melanoma cells and Chang cells. A high proportion of the patients and their relatives
were found to have low NK activity against these target cells. In most of the patients
this could not be attributed to general depression of their immune function, since B-
and T-cell numbers and the mitogenic response to PHA were within normal limits.
The levels of NK activity of the patients and their relatives were found to be signifi-
cantly correlated, suggesting that the NK activity in these families may have been
genetically (or environmentally) determined. Several genetic markers were ex-
amined in the patients and their relatives for association with the disease state and
NK activity. No association with HLA antigens or ABO blood groups was detected,
but there was a low incidence of the Rhesus negative phenotype in the patients (the
Rh phenotype had previously been associated with high NK activity).
The present results indicate that NK activity has a familial association in families
with a high incidence of melanoma, and raise the question whether low NK activity
may be one of the predisposing factors in the development of familial melanoma.
A NUMBER OF REPORTS have confirmed
that certain families have a higher inci-
dence of melanoma than that expected in
the general population, and that this
appears to be attributable to hereditary
factors (Cawley, 1952; Anderson, 1971;
Wallace & Exton, 1972). Patients in these
families tend to develop melanoma at an
earlier age, have a higher frequency of
multiple melanomas and a greater inci-
dence of other malignancies. The nature
of the factors predisposing members in
these families to develop melanoma and
their inheritance is unknown. In most
studies the inheritance appeared to be
polygenic, but in some families autosomal
dominant inheritance was evident (Ander-
son, 1971; Wallace & Exton, 1972).
One of the factors considered to be
important in control of tumour develop-
ment is surveillance by the immune
system. In particular, recent studies have
suggested that cells with natural killer
activity against tumour cells may con-
stitute an important surveillance mech-
anism against tumours (Kiessling & Haller,
1978; Hersey, 1979; Baldwin, 1977). This
suggestion was supported by recent find-
ings that melanoma patients with low
natural-killer (NK) cell activity may have
a shorter period to recurrence ofmelanoma
than those with normal or high NK
activity (Hersey et al., 1978).
In the present study the NK activity of
patients with familial melanoma and their
relatives was examined to determine
whether this immune function may be
involved in the familial occurrence of
melanoma. The results suggest that a high
proportion ofpatients with familial melan-
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oma and their relatives had low NK
activity which did not appear to be
associated with abnormalities in other
aspects of immune function.
MATERIALS AND METHODS
Patients with familial melanoma and their
relatives.-Thirteen families in which more
than 1 patient with melanoma had been
documented by histopathological criteria
were included in the study (18 patients and
53 relatives). The known member of each
family are listed in Appendix I, but not all
were available for study. Patients with a
history of melanoma are indicated by an
asterisk. All were clinically free of melanoma
and, with the exception ofWhit, had been so
for longer than 1 year. All were untreated.
Their ages ranged from 18 to 65 (mean 42.5)
years. Most ofthe patients and their relatives
were from country areas and repeat tests on
many of these subjects were not possible.
Patients with non-familial melanoma and
their relatives.-For comparative purposes,
patients who had previously had melanoma
but who were clinically free ofmelanoma were
taken as index subjects for study of their
available relatives. Patients were selected on
the basis of previous studies to provide a
range of NK activity, so that any genetic
influence of NK activity could be detected
more readily in their relatives. Studies on
family groups were carried out on the same
day when possible, to minimize the effects of
day-to-day variation in the assays. The ages
of the patients ranged from 25 to 72 (mean
45-5) years.
Normal subjects and their relatives.-Nor-
mal blood donors or hospital personnel with
high or low NK values were taken as index
subjects. All available relatives and the index
subjects were tested if possible on the same
day. Ages ranged from 21 to 53 (mean 31-1)
years.
Assays of NK activity.-The cytotoxic
activityofbloodmononuclear cells against the
target cells was determined by 5lCr-release
assays, as described in previous reports
(Hersey et al., 1978). The effector cells were
mononuclear cells obtained from defibrinated
venous blood by centrifugation on Hypaque-
Ficollmixtures. Allassayswere carried out on
blood samples taken the same day.
Target cells were from the MM200 melan-
oma cell line established from a primary
melanoma in the Queensland Institute for
Medical Research, and the Chang cultured
human liver cell line (Commonwealth Serum
Laboratories, Melbourne). 51Cr-labelling was
carried out by incubation with 100 FLCi ofNa2
5'CrO4 for 2 h at 37°C. Target cells (3 x 103 in
0)5 ml) were incubated with effector cells
(3 x 105 in 0-5 ml) overnight in duplicate
10 x 70mm round-bottomed tubes. Culture
medium was RPMI plus 10% foetal bovine
serum FBS (Batch 64, Australian Laboratory
Services).
Percent 51Cr release was calculated as pre-
viously described. All results were expressed
in terms of percent 51Cr release above base-
line release from the target cells alone. To
assess the day-to-day variation in the assays,
a standard NK donor was used in each assay
from cells stored in liquid N2 from the one
donor. All assays were carried out by the one
operator (A.E.) which we consider to be an
important factor in reduction of day-to-day
variability in the assays.
E rosettes.-These were carried out by the
method of Kaplan & Clark (1974), using
aminoethylisothiouronium bromide (AET)
treated sheep red blood cells (SRCB). 200 ,ul
of 1% AET-SRBC and 200 ,lI of a suspension
of blood mononuclear cells of 2 x 106 ml were
mixed and incubated at 37°C for 15 min.
They were centrifuged at 300 g for 5 min
and incubated at 4°C for 1 h.
Mitogenic response to PHA.-105 mono-
nuclear cells in 200 ,u of RPMJ+10% FBS
were cultured for 3 days in 0, 5 or 20 /g of
PHA-P (Difco). Cell division was assessed at
this time by the addition of 2 ,uCi of 1251-
iododeoxyuridine (125IUDR) for 4 h and then
harvested by washing the cells twice in saline
and twice in 5% trichloracetic acid.
Blymphocytes.-Cells with surface immuno-
globulin were detected by use of fluorescein-
labelled polyvalent sheep anti-human im-
munoglobulin (Wellcome reagents). 5 x 105
lymphocytes were exposed to acetate buffer
at pH 4-5 for 1 min at 4°C to remove non-
specifically bound surface immunoglobulins
(Kumagai et al., 1975), then washed in
phosphate-buffered saline (PBS). The cells in
50 ,ul PBS were incubated in 100 ,ul of a
1-in-8 dilution of the antiserum for 20 min at
room temperature and then washed x3 in
PBS. They were then mounted in PBS:
glycerol, pH 8-2, and examined by fluorescent
microscopy.
Statistical analysis.-The relationship be-
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tween NK values of patients and their
first-degree relatives was tested for signifi-
cance by t test of the correlation coefficient
ofthevalues, usingtheformulat=rV,/n-2/l-r2.
The significance of the difference in the pro-
portion of familial melanoma patients with
low NK activity compared to non-familial
melanoma patients was estimated by Chi-
square tests and Fisher's exact probability
test of the data. The relationship of low NK
activity to particular HLA antigens and
Rhesus antigens was also estimated by Chi-
square test ofthe data.
RESULTS
1. Reproducibility of the assays
The NK activity of the stored mono-
nuclear cells from the control donor was
tested on 14 occasions in parallel assays
with those carried out on mononuclear
cells from subjects belonging to the
familial melanoma families. The mean
NK activity of the stored cells against the
MM200 target cell was 7-8±1-9 (s.d.).
Against the Chang cells, equivalent values
were 7 8±2 2. To illustrate further the
reliability of the assays, the NK values
for 2 laboratory donors from repeated
tests over a 12-month period correspond-
ing to that of the studies on the familial
melanoma patients against the MM200
target cell were recorded. In 10 assays on
these 2 normal individuals the means of %
51Cr release were 13 6±1i5 and 29 9±2-0.
These results indicate that values ob-
tained by single tests on a subject were
likely to give a reliable indication of the
inherent NK activity of that person, and
did not merely reflect chance variation in
the assays. When repeat assays were
available on the subjects in the study,
there was little variation between the
tests, as shown in the following tables.
Similar degrees of variation in repeated
tests on the same individual were reported
by Rosenberg et al. (1974).
2. Natural cell-mediated cytotoxicity (NK
activity) offamilial melanoma patients and
their relatives
The NK activity of blood mononuclear
cells from patients and available family
members against the MM200 and Chang
target cells at a ratio of 100:1, effector:
target cell, is shown in Table I. The mean
NK value of 80 normal subjects was
14-97±5-78 for the MM200 target cell
(Hersey et al., 1978) and 14-68±6'2
against the Chang target cell (Hersey et al.,
1979b). [This latter value was higher than
the mean value of 9.6% recorded in
Hersey et al. (1978). We attribute this to
the use of a different line of Chang cells
supplied to us from CSL, Mebourne, before
the present study).] Based on these data.
values less than 10% 51Cr release (i.e. less
than 1 s.d. below the mean) were con-
sidered as "low" and values greater than
20% (i.e. greater than 1 s.d. above the
mean) as "high". The results in Table I
indicate that 12/18 patients in 9/13
families (Shr family excluded) with
familial melanoma had low NK values to
the MM200 and/or Chang target cell
(proportion of total patients-=067). Two
patients in 2 families (Kni and Smi) had
high values, and 4 patients in 4 families
(Ree, Red, Bur and Dan) had values
within the normal range. No patients
were available for study in Family Shr,
but the values in the relatives are shown.
These were not included in the analyses.
The proportion of non-familial melan-
oma patients with localized melanoma
with less than 10% 51Cr release against
the MM200 target cell, measured after
surgical removal of melanoma in a study
on 74 patients (Hersey et al., 1978) was
0-39 (29 patients). Comparison of the
different proportions of familial and non-
familial melanoma patients with values
less than 10% gave a value of 5-39 by Chi-
squared test (0-025>P>0 01) and P=
0-024 by Fisher's exact test.
The second point to be noted from the
table is that the relatives of patients with
familial melanoma also tended to have
similar NK values against the 2 target
cells (e.g. the children in Families Kni and
Red also had high NK values, and the
relatives of Families Mor, Leu, Pea, Cow,
Whi had low NK values). The correlation
of the NK values of relatives with those
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TABLE I.-Cell-mediated cytotoxicity ofpatients and relatives ofpatients withfamilial
melanoma
Target
Family cellt
Kni M
C
Edw M
C
Mor M
C
Leu M
C
Pea M
C
Dan M
C
Shr M
C
Bur M
C
Cow M
C
Ree M
C
Whi M
C
Red M
C
Whit M
C
Smi M
C
Patient
34-5±1-5
14-5± 2-5
5
3
3
6
3
9
3
5
4
1
11
7
6
6
20
13
9±1-8
5±0
18±2
14±0
5-3± 1-4
7-3± 1-8
25
10
Siblings Children
23
16
10, 14
10, 13
Second-
degree
Parents relatives
11, 9 23
9, 16, 19
20. 30
10. 8
10, 5, 7 k
12, 4, 6
7-5± 1-4
4±0, 10±1-6
9±0, 9-5±1-4
9±0
6, 5*
6, 6
13*
10
8 3±1*5, 8±2
5, 0
8, 10
95± 1-4, 14-5±2-2
5±0, 8-5±1-8*
5±0, 8±2
14
4
4
9, 15, 14
3, 8, 6
0
12*, 15, 10, 3
10, 18, 10, -
6, 9
10. 6
20
9, 9±5
8±0, 6±0, 8-5±0-5
8-5±1-6, 8+1-0
16±1-6, 21-5±2-5
14±2, 8±0, 12±2
t M=MM200 and C=Chang target cells.
* Relatives with melanoma. Values given are % 51Cr release above baseline 51Cr release from target cells
alone at aratio of 100: 1 effector:target cells. Spontaneous release for both target cells ranged from 23 to 42%. Standard errors (s.e.) of single tests were <2%. Where 2 or more tests were carried out the s.e. are shown.
of the familial melanoma patients is
shown in the Figure. Whit and Smi were
not included in this analysis because rela-
tives were not available for study. The
correlation coefficient (r) examined by t
test was highly significant (a) against the
MM200 target cell (r=0'48, 0O005>P>
0O001) and significant (b) against the
Chang target cell (r_034, 0O05>P>
0025). The correlation ofthe NK activity
of familial melanoma patients with that
of their distant relatives (cousins and
uncles) was also examined as shown in
Figure (c), but no significant correlation
was found (r-=0 17).
3. NK activity of non-familial melanoma
patients and their relatives
The NK activity of 15 melanoma
patients and their close relatives studied
over the same period is shown in Table II.
The purpose of this study was to deter-
mine whether the NK activity of their
relatives would be similar to that of the
patient, and patients were therefore
selected to provide a range of high, nor-
12, 29
4, 20
6, 6 11
6, 6 10
16
7
30
20
20
9
26
20
9, 5, 10, 7
10, 5, 17, 4
4
6
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FIG.-Correlation of NK activity of familial-melanoma patients with that of their relatives. (a)
MM200 target cell; r=0-48 (0005>P>0001) (b) Chang target cell; r=0-34 (0-05>P>0-025)
(c) NK activity against Chang and MM200 target cells of patients compared to that of their
distant relatives (r=0-17, N.S.).
mal and low NK values. There was some
evidence that NK values of relatives did
correlate with those of the patients. For
example, Patients Heb, Ral, Lev and
their close relatives had low NK values;
Patients Buc, Che and Sla and their rela-
tives tended to have high NK values; and
Patients Law, Fen, Pom and their rela-
tives had normal NK values. The one
exception was Patient Ben, with high NK
values that were not reflected in that of
the relatives. The correlation coefficient
between patients and their relatives was
significant for NK activity against the
Chang cell (r- 0.29, 0-05>P>0-025) but
not against the MM200 target cell (r=022,
0.10>P>0.05).
4. NK activity of normal subjects and their
relatives
Similar studies were carried out on the
families of 12 normal subjects to deter-
mine whether a familial association ofNK
activity could be deteted in normal sub-
jects. Index subjects were again selected
with high, low and normal NK values.
The results in Table III again suggest that
NK values of relatives tended to be
similar. Correlation coefficient against the
MM200 was 0-14 (N.S.) but against the
Chang cell was 0'38 (0.02>P>0-01).
Unfortunately the data are insufficient to
detect whether a particular pattern of
inheritance of NK activity in these
families (e.g. with Family Ayl, if the NK
value of the missing parent were high,
genes from this parent might have been
responsible for the high NK values of the
other sib. Similarly, with Family Mur one
sib had high and the other low NK values
against the target cells. One parent had
low values and it would have been helpful
to know the NK value ofthe other parent.
5. General immunefunction ofpatients with
familial melanoma and their relatives
The E rosette (T cell) and surface
immunoglobulin (B cell) percentages in
peripheral blood, and the mitogenic re-
sponse to PHA in patients and relatives
of 7 of the melanoma families are shown
in Table IV. Mean values +s.d. on 26
normal controls carried out over the same
period were 61 11 for E rosettes and
18 7 for surface immunoglobulin-bearing
cells. For PHA at concentrations of 0, 5
and 20 ug these values were 800+600,
8230±4200, and 9100+5300 ct/min. Some
members of the Families Pea and Shr had
low PHA responses, and one patient Mor
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TABLE II.-Cell-mediated cytotoxicity ofnon-familial melanomapatients and their relatives
(Symbols as in Table I)
Children
7±0 5, 13
5±0, 25
14±1-0
13
15, 6
11, 5
13
6
Parents
7-5±1O0
6±0
5±0
6±0
18±3
12±2
8*5±2
74-12
40, 38
20, 11
4, 1
14, 9
15, 30
25, 22
16, 36
21, 28
4 0, 17±192
14, 8±0*6
12 2, 2
11 3, 3
18, 17, 17 18, 16
21, 22, 25 18, 17
See footnotes to Table I. S.e. calculated from at least 4 repeat tests.
had low E-rosette values, but all other
patients and relatives appeared to have
normal values. Most of the members of
these families had low NK activity (see
Table I).
DISCUSSION
The incidence of familial melanoma has
been reported to be from 1 to 6% of all
melanoma patients (Clark et al., 1977;
Anderson, 1971). However, only 18 such
patients were available for the present
study in this unit, and it is apparent that
caution is needed in assessing the signifi-
cance of studies on such small numbers of
patients. Nevertheless on a statistical
basis our studies suggested that familial-
melanoma patients had a lower NK
activity against cultured melanoma and
Chang target cells than non-familial-
melanoma patients. In addition it was also
apparent that high or low NK values in
the familial-melanoma patients were re-
flected in close relatives but not in distant
relatives.
These findings were consistent with a
genetic or environmental influence on NK
activity in these families, which was
diluted in the distant relatives. Analysis
of the NK activity in normal families and
non-familial-melanoma families also re-
vealed a familial association of NK
Family
Jay
Heb
Target
cell
M
c
M
c
Patient
12*6+2 0
12±1 7
9 9± 19
7-7± 17
31 3±2 9
7 3±b15
31±3
27-3± 1*8
15±1*5
4±b10
8±1*7
13±2
23±2*5
8±0 6
22+2
21±2*6
9±1b8
18±1*8
18±1*4
7±1b4
11±1*5
15±2 2
11±1*7
6±U12
43± 1*2
17±0
8±2
17
18
Siblings
75±1*6
4±2
5-5±0 6
4±1
12±2
6±1
8, 15, 9±P14
6, 9, 7±1*4
16
9
8, 4, 4
15, 9, 10
22
6
7, 22
7, 11
3
16
50
35
10, 14
24, 27
20, 10, 11
16, 10, 7
20, 33
20, 20
Yat M
c
Ben M
c
Law M
c
Ral M
c
BuC M
c
Che M
c
Lev M
c
Sla M
c
Tay M
c
Fen M
c
San M
c
Gre M
c
Pom M
c
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TABLE III.-Cell-mediated cytotoxicity of normalfamily members
Target Index 2nd-Degree
Family cell subject Siblings Children Parents relatives
Ayl M 4 28 20, 14 7
C 6 16 21, 11 7
Cur M 21 7,20 16,11
C 19 10, 15 30, 23
Don M 6 12 13
C 8 15 11
Gill M 7 5,15,19 18
C 9 12,6,8 11
Tho M 7 14,11 6,14
C 11 10,2 3,12
Wot M 24±0 - 21,12 8,16
C 18±0*8 20, 10 8, 14
Dil M 17 9,8
C 8 6,8
Ash M 8 6 9
C 14 7 16
Gar M 10±0-5 2, 18 6, 11
C 9±141 0, 15 2, 15
Mur M 29-9±2-0 5 25 8
C 6±1-8 2 18 3
Her M 7-7±1-3 5,2,2
C 6-7±1-4 18, 23, 10
Kra M 9 4,10 3
C 15 10,16 12
See footnotes to Table I.
TABLE IV.-General immune function offamilial-melanoma patients and their relatives
PHA response ct/min
%E % Ig+ A
Subjects rosettes cells 0 5 ,ug 20 ,ug
F. Shr (c) 68 - 1670 7020 7147
P. Shr (c) 54 748 2072 5041
R. Wyn (c) 72 443 1742 3458
L. Gre (c) 50 489 1967 2536
J. Edw (p) 50 28 1868 6478 4514
N. Edw (m) 58 20 1350 4968 4958
J. Edw (b) 60 22 629 15290 13534
G. Edw (b) 56 26 635 7672 7366
E. Mer (p) 42 25 855 6942 8185
N. Dan (p) 50 32 1590 3880 6188
S. Dan (c) 70 26 1660 6627 13940
B. Dan (c) 52 20 1330 11550 15300
I.Dan (c) 62 18 1100 5807 7670
A. Leu (p) 60 20 1264 2243 5308
J. Tho (c) 72 25 1472 7590 10509
E. Enl (s) 70 - 703 6102 6892
B. Murr (s) 52 25 1140 10460 6070
A. Bur (p) 56 28 720 11060 14500
R. Bur (c) 60 32 530 10285 12893
T. Bur (c) 68 22 940 7174 13330
T. Bur (c) 60 32 1644 12520 15500
L. Bre (m) 58 36 1170 14803 15040
C. Pea (p) 60 18 396 2130 3620
S.Jan (p) 66 26 505 2300 3804
P. Pea (m) 68 550 2275 3260
(p), (m),(c), (s) and (b) = patient, mother, child, sister and
brother respectively.
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activity against the Chang cells, but the
association was not so apparent against
the melanoma cells. These results indicate
that the genetic or environmental in-
fluence on NK activity in these latter
families may not have been as strong as in
the familial-melanoma families. It should
be emphasized, however, that the method
of analysis was designed to detect broad
associations ofNK activity in families and
was not suitable for detection of patterns
ofinheritance within the family groupings.
The data currently available are in-
sufficient for such an analysis to be made,
although in some instances autosomal
dominant inheritance of NK activity was
apparent. This mode of inheritance would
be consistent with that in mice, where it
was found that the genes determining NK
activity were linked to the H2 antigens
(Kiessling et al., 1975; Roder & Kiessling,
1978).
Analysis of the HLA phenotypes of the
familial-melanoma patients in this study
showed that the HLA A2 phenotype had
a higher frequency than expected in the
normal population, but the family segre-
gation ofHLA revealed no linkage with the
disease state (Honeyman et al., in prepara-
tion) or with high or low NK activity.
Previous studies have also failed to show
any relation between melanoma and HLA
antigens (Takasugi et al., 1973).
Another genetic marker which we have
recently shown may be associated with
NK activity is the Rhesus antigen system,
in that Rh- subjects appeared to have
higher NK activity than Rh+ subjects
(Hersey et al., 1979b). Examination of
patients and relatives in this study re-
vealed a low incidence of Rh- subjects.
Additional studies are required to estab-
lish the significance of these findings, but
it could be speculated that genes deter-
mining high NK activity may be linked to
those coding for the Rh- antigens and that
both gene pools were absent in these
family groups with melanoma.
Whether low NK activity has biological
significance for the development of melan-
oma is unknown. Previous studies in
animals (Kiessling & Haller, 1978) and in
melanoma patients (Hersey et al., 1978)
have suggested that NK activity may have
a surveillance role against tumours. It
would therefore be plausible that the low
NK activity in these families was one
factor in the development of melanoma.
Other factors are apparently involved,
however, because some of the familial-
melanoma patients appeared to have high
NK activity to melanoma cells. There was
no evidence from our studies that other
deficiencies in immune function were
involved in the familial incidence of
melanoma, in that the general immune
function of most of the patients and their
relatives with low NK activity who were
available for testingappearedto benormal.
We hope the reporting of these findings
may prompt study of familial-melanoma
subjects in other areas by these assays.
The present study also highlights the need
for more complete genetic analysis of NK
activity in human subjects, and prompts
the question whether low NK activity
may be a predisposing factor to develop-
ment of certain malignancies.
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APPENDIX I
Patients withfamilial melanoma and their relatives
Patients
J. Kni
D. Ree
J. Edw J.
G.
Grand-
Sibs Children Parents parents
B. Kni J. Tay* E. Bir
W. Kni W. Tay Bir
A. Tay
M. Tay
G. Ree A. McA
T. Ree* A. McA
T. Ree
E. Ree
Edw - N.Edw C.Whi
Edw H. Edw Whi
H. Hav
Hav
E. Mor
A. Leu E. Eul
B. Mur
R. Had
+5
unidentified
C. Pea S. Jan*
R. Pea
M. Pea
E. Cowt -
N. Dan D. Der
J. Der*
B. Der
L. Der*t
A. Bur
L. Jon*
P. Dav
J. Tho
G. Bri
Bri
R. Leu
F. Leut
J. Sto
Sro
Leu
Leu
M. Pea O. Llo
P. Pea J. Llo
A. Pea
A. Pea
N. Cow E. Cow E. Mart
J. Rob* Cow Matt
E. Cow Cowt
W. McD* Cowt
B. Dan R. Der Der
S. Dan Der Der
I. Dan Fra
Fra
S. Bur*
T. Bur
T. Bur*
R. Bur
R. Whi J. Pri C. Whi
E. Pri*t L. Smi
E. Whi
L. Whi
M. Red B. Bar* D. Red
K. Tul L. Red
N. Naa D. Red
P. Tul
W. Shr*t F. Shr*t
T. Shr
K. Shr*t
J. Shr
B. Whit W. Whit*
F. Whit
D. Smi J. Smi
E. Smi*
B. Smi
M. Smi
R. Wyn
L. Gre
P. Shr
F. Shr
S. Whit
D. Whit
G. Smi
W. Smi
J. Smi
B. Smi
L. Bur
L. Bur
Bur
Bur
A. Prit Prit
R. Prit J. Prit
C. Maht
Maht
G. Tult Cot
R. Tult H. Cot
B. Tul
J. Tul
F. Shr*t
2° Relatives
0. Lew D. Pug
R. Bir
G. Bit
J. McG
P. Wal*
A. Leu*
L. Smi
L. Cun
L. Pla
R. E.
J. Cow A. Cow
M.
M.
D. Pri J. Pri
C. Per J. Pri
J. Pri R. Pri
M. Rie
B. Shr*t
N. Whit
M. Whit
R. Smi*
P. Smi
* Melanoma. t Deceased.
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